OTCMKTS: CMVLF
Insilico Medicine and Luoxin Pharmaceutical Forge Long‑Term Strategic Collaboration on AI‑Enabled Drug Discovery in Chronic Diseases
Insilico Medicine (HKG: 3696), an AI‑powered drug discovery company, and China‑based Luoxin Pharmaceutical Group Co., Ltd. (SHE: 002793) jointly announced that they have entered into a long‑term strategic collaboration on…
Empowering Chinese Pharma’s Global Expansion
Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
